[Diagnostic Value and Health Economic Evaluation of Ultrasound-Combined Fine-Needle Aspiration Cytology in Primary Breast Cancer].

Ying-jian He,Jin-feng Li,Tian-feng Wang,Yun-tao Xie,Zhao-qing Fan,Tao Ouyang
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2012.46.013
2012-01-01
Abstract:OBJECTIVE:To explore the diagnostic value and health economic evaluation of ultrasound-combined fine-needle aspiration cytology for axillary lymph node status in breast cancer.METHODS:We reviewed retrospectively collected the data from 2503 cases of biopsy-proved breast cancer (T0-2) at our breast center between May 2005 and June 2010. The diagnostic fees of ultrasound-combined fine-needle aspiration cytology and clinical examination were calculated and assessed with cost-minimization analysis.RESULTS:Ultrasound-combined fine-needle aspiration cytology prevented 10.9 percent of the patients with positive clinical findings from unnecessary sentinel lymph node biopsy and achieved a saving of 155.55 RMB per patient. However, only 29.4 percent of the cases were diagnosed with ultrasonographic abnormal axillary nodes.CONCLUSIONS:Ultrasound-combined fine-needle aspiration cytology has great application values. The ultrasonic diagnostic criteria of abnormal axillary nodes should be loosened.
What problem does this paper attempt to address?